Last reviewed · How we verify
DIetary Supplements, Executive funcTions and Vitamin D (DIET-D): a Double-blind Randomized Controlled Trial
The purpose of this study is to compare the effect after 12 weeks of the oral intake of Lecitone®Se + 200UI/day of D3 vitamin with the effect of a placebo on changes in cognitive performance in Trial Making Test score part B (this test evaluate executive functions of mental flexibility) in older adults with Mild Cognitive Impairment (MCI).
Details
| Lead sponsor | University Hospital, Angers |
|---|---|
| Phase | Phase 2/Phase 3 |
| Status | UNKNOWN |
| Enrolment | 160 |
| Start date | 2012-11 |
| Completion | 2014-11 |
Conditions
- Mild Cognitive Impairment
Interventions
- Lecitone®Se-Vitamin D3
- Placebo
Primary outcomes
- Change in executive performance — This outcome is assessed at baseline, 12 and 24 weeks after inclusion.
Executive performance is measured with Trial Making Test part B (TMT B)
Countries
France